Lumenis VersaCut Recall: Mislabeling Could Lead to Air Embolism

Recent problems with the warnings and instructions provided on a medical device used to remove tissue during surgery, which could cause an air embolism if the tubing is hooked up backwards, has been categories as a Class I recall due to the serious risk of severe adverse health consequences or death.ย 

The FDA determined on Monday that an “Urgent Safety Advisory Notice” sent out last month by Lumenis Limited regarding the VersaCut Tissue Morcellator constitutes the most serious category of medical device recalls, involving situations where continued use of the product poses a reasonable probability of death or severe injury.

The Lumenis VersaCut Tissue Morcellator recall was posted on the FDA website on February 25, after the manufacturer re-labeled the product on January 2, due to a risk of users hooking up the aspiration tubing backwards to the aspiration control box.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The recalled Lumenis VersaCut Tissue Morcellator products are used to break up and remove tissue during surgeries where access to the surgical area is limited. Because of inaccurate instructions the devices may be assembled backwards, potentially causing air embolisms to occur during surgery.

The recall affects the VersaCut Morcellator starter kit with model number 0637-245-01 and control box with model number 0636-470-01. All VersaCuts manufactured by Lumenis Limited since May 1998 are included.

In the letter sent out by the manufacturer on January 2, customers were directed to re-label the device with two new warnings provided and to replace the Operator’s manual with a revised copy. Customers were also asked to return a confirmation card to verify that the steps were taken.

The FDA has indicated that the Lumenis VersaCut should be quarantined and use should be discontinued until the Operatorโ€™s Manual has been replaced or fixed. Consumers may submit reports online at www.fda.gov/MedWatch/report.htm or call 1-800-332-1088 top request a reporting form. For further questions regarding the devices consumers may contact VersaCut Morcellator field correction administrator at +972-(54)-9599196 or +972-(4)-9599296 or via email at VersaCutMorcellator@lumenis.com

Written by: Russell Maas

Managing Editor & Senior Legal Journalist

Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nationโ€™s leading personal injury law firms and oversees the siteโ€™s editorial strategy, including SEO and content development.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

In a joint statement, plaintiffs and defendants in AngioDynamics port catheter lawsuits have laid guidelines for what types of cases should be selected to serve as potential bellwether trials.
Women who experienced infection, chronic inflammation, implant instability or other complications after internal bra mesh procedures are now questioning whether those risks were fully disclosed before implantation.
More than 3,300 women have filed Depo-Provera lawsuits in federal court, with several hundred more also pending in state courts in New York and Delaware, according to a recent status report.